The study have demonstrated that NSD1 counteracts Polycomb‐repressive complex 2 (PRC2) through collaboration with SWI/SNF complex, and the study have identified the co‐occurrence of NSD1 inactivation in SWI/SNF‐deficient cancers, which indicates its relevance in vivo [57]. This evidence concerns the gene SMARCA1 and cancer.